Indolent Systemic Mastocytosis — Trials

Indolent Systemic Mastocytosis — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03770273	Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis	completed	Phase 2	21	National Institute of Allergy and Infectious Diseases (NIAID)NIH	1	Dec 17, 2024	clinicaltrials
NCT00814073	Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis(AB06006)	completed	Phase 3	135	AB ScienceINDUSTRY	2	Dec 3, 2019	clinicaltrials
NCT03632811	Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language(Mc_QoL)	completed	—	30	University Hospital, ToulouseOTHER	1	Jul 17, 2019	clinicaltrials

Data updated 22 days agoSource updated Dec 17, 2024source: clinicaltrials